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INTRODUCTION
Sarcoidosis is a systemic granulomatous disease, which may in volve any part of the eye and its adnexal tissues. Although the first manifestation of systemic sarcoidosis is often ophthalmic involve ment, nonophthalmologists are not familiar with its ocular man ifestations, especially when described in ophthalmologic terms. In this article, the author intends to describe the ocular manifestations of sarcoidosis in the terms of a nonophthalmologist.
EPIDEMIOLOGY
The prevalence of ocular involvement of sarcoidosis ranges wide ly. Ocular involvement has been reported in 1223% of biopsyprov en sarcoidosis cases in the United States [1] , and was reported in 13% of cases in Turkey and 79% in Japan [2, 3] . In South Korea, prev alence was reported at 21% in 2009, which was similar to that of the United States [4] . It is notable that the prevalence in South Ko rea was different from that in Japan. This discordance may be due to the relatively small sample size of patients in these observations.
Both of the studies in South Korea and in Japan were conducted using about 100 patients, which is a large number for a single insti tute, but not for the result of a large study. Thus, it is somewhat challenging to determine the prevalence of ocular involvement in all patients with sarcoidosis based on the results of this single study.
However, among patients with uveitis, the prevalence of sarcoi dosis as a preexisting condition is another interesting topic for ophthalmologists. A review of 209 patient records with diagnosed uveitis in Thailand showed that 4 patients (2%) were also diagnosed with pulmonary sarcoidosis [5] . In a retrospective study performed with 3,060 patients in 41 university hospitals in Japan in 2007 [6] , the root cause of uveitis was found to be sarcoidosis in 407 (13.3%) of all uveitis cases. On the other hand, in the report of a single in stitute in the United States in 2008, sarcoidosis was identified as a root cause in only 7% of the uveitis cases [7] . The study result from Japan may differ from the United States study because the Japa Sarcoidosis is a granulomatous disease which frequently involves eyes and adnexal tissues. Its prevalence of ocular involvement is reported as about 20%, although it varies widely according to authors, from 12% to 73%. Ocular sarcoidosis is present as various forms -uveitis, conjunctival involvement, optic nerve involvement, and orbital involvement. All the forms of uveitis -anterior uveitis, intermediate uveitis, posterior uveitis and panuveitis -can be shown in sarcoidosis. Because clinical manifestation, prognosis and treatment are determined by the location of uveitis, it is important to classify uveitis. Conjunctival involvement is not a sight-threatening condition in general, its diagnostic value may be of use. Optic nerve is the most commonly involved cranial nerve, which can impair vision. Subjects with visual impairment without any evidence of uveitis, optic nerve involvement should be suspected. Orbital involvement, especially lacrimal gland involvement is common, and it may cause mass-effect. Besides systemic administration of drugs, there are several localized treatments for ocular sarcoidosis -topical eye drops, intra/peri-ocular injection of agents. 
UVEITIS
Uveitis is difficult to define, but usually indicates an inflamma tion in the eyes. Uveitis is often considered the inflammation of tissues known as the uvea: the choroid, ciliary body, and iris. This 
ANTERIOR UVEITIS
Anterior uveitis is the most common form of uveitis. The ante rior part of the uvea includes the iris that surrounds the pupil and the adjacent ciliary body that synthesizes aqueous humor, the flu id that fills the front of the eye. In sarcodosis, the development of anterior uveitis is common, with about 40% of cases presenting with anterior uveitis according to a report in Korea [4] .
The anterior chamber-the space including the cornea, iris, and lens-is filled with aqueous humor, and its inflammation is one of the most common findings in patients with sarcoidosis. It has been reported that about 90% of patients with sarcoidosis and ocular involvement display anterior chamber inflammation [8] . As this finding is very common, it does not have great value in diagnosing sarcoidosis. However, because it can cause comorbidity as well as symptoms such as pain, redness, photophobia (sensitivity to light), increased ocular pressure, and posterior synechiae (irislens adhe sion), it is necessary to identify and control this inflammation.
Granulomatous uveitis is known to occur specifically when there is ocular involvement of sarcoidosis. The term "granuloma" in "granulomatous uveitis" is different from the usage of "granulo ma" describing sarcoidosis in "granulomatous inflammation."
The term "granuloma" in "granulomatous uveitis" does not indi cate "granuloma" in "granulomatous inflammation". The term "granulomatous uveitis" is applied when at least one of the follow ing clinical signs are observed: (1) large muttonfat keratic precipi tates (an accumulation of inflammatory leukocytes that deposit on the corneal endothelium), (2) iris or trabecular meshwork nod ules, or (3) choroidal granulomas [9] . In other words, even though "granulomatous uveitis" as a clinical term can be readily found in reference to sarcoidosis, it can also be found in uveitis not associat ed with sarcoidosis, and is seen in VogtKoyanagiHarada Syndrome, multiple sclerosis, Fuchs' heterochromic iridocyclitis, metastatic tumors, and ocular infections as a nonspecific finding [10] . Nev ertheless, an iris nodule is a relatively specific finding in sarcoid osis, and has clinical value as it may resolve with medical treatment.
INTERMEDIATE UVEITIS
Intermediate uveitis refers to inflammation localized to the vit reous and peripheral retina. Intermediate uveitis manifests with symptoms such as visual floaters and visual impairment (media opacity and cystoid macular edema). Cystoid macular edema is a cystic change in the macula, mostly affecting vision in regions of the retina, and involves bloodretinal barrier breakdown due to inflammation [11] . Intermediate uveitis is a relatively common oc ular manifestation of sarcoidosis, and accounts for about 31% of all uveitis in sarcoidosis patients, according to one domestic report in Korea [4] . 
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POSTERIOR UVEITIS
Posterior uveitis involves the retina and choroid, and manifests in sarcoidosis as retinal vasculitis with or without panuveitis, and multifocal choroiditis (punched out chorioretinal scarring) with or without evidence of posterior segment inflammation such as vitritis or cystoid macular edema [12] . Posterior uveitis has been known to occur more commonly in elderly white females, but con flicting data exists regarding prevalence among different reports [2] . In a domestic report from Korea [4] , it was reported that poste rior uveitis was observed in about 28% of patients with definitively diagnosed ocular sarcoidosis, and retinal perivasculitis and spotty retinochoroidal exudates were seen in 67.3% and 53.9%, respec tively [3] . It is also known that generally posterior involvement oc curs in both eyes, but they are not always symmetric. 
CONJUNCTIVAL INVOLVEMENT
The conjunctiva is the tissue which lines the outer wall of the eyeballs, sclera, and the inner surface of the eyelids. Although con junctival involvement of sarcoidosis is relatively common, it is fre quently overlooked because there are often no clinical symptoms.
Conjunctival involvement can occur both in the palphebral con junctiva and the bulbar conjunctiva with symptoms of redness and irritation, or can present as cicatricial conjunctivitis. Conjunc tival involvement is significant because the conjunctiva is at the most superficial part of the eyeball, and biopsy in this area is very easy. In patients with biopsyproven sarcoidosis, conjunctival in volvement was found in 5571% of conjunctival biopsies [19, 20] .
OPTIC NERVE INVOLVEMENT
In addition to the facial nerve, the optic nerve is the nerve that is most commonly involved in cranial neuropathies of sarcoidosis [21] . The symptoms vary by the location of the granuloma, and vi sual impairment or even loss of vision may occur depending on the involvement of the optic nerve as well as the visual pathway.
Papilledema may be also found depending on the increased intra cranial pressure, but papillitis is sometimes found because of uve itis alone even though there is no increase in intracranial pressure.
Irreversibly impaired visual acuity occurs in more than half of those with direct optic nerve involvement [22] .
ORBITAL INVOLVEMENT
Sarcoidosis can have various symptoms because it can involve orbital fat, the optic nerve sheath, lacrimal gland, and extraocular muscles. Caution is required because there is a mass effect within the eyeballs, and clinical findings may be similar to thyroid orbi topathy [23] .
The lacrimal gland is the organ that is most commonly affected within the orbit. The involvement of the lacrimal gland was found in 63% of patients with a definitive diagnosis of orbital sarcoidosis in one study which reviewed 30 patients in a single facility [24] .
The involvement of the lacrimal gland often does not have symp toms and is not clinically significant. If the size of the sarcoid mass is large, the mass may be palpable and there may be symptoms due to the mass effect. When the extraocular muscles are involved, dip lopia is occasionally presented [25] .
IS OPHTHALMOLOGIC TESTING REQUIRED FOR ASYMPTOMATIC PATIENTS WITH SARCOIDOSIS?
Tentshaped peripheral anterior synechiae (PAS) and posterior synechiae of trabecular meshwork can cause an increase in ocular pressure, and may not be apparent in the early stages. It has been reported that 8 of 22 patients (36.4%) with ocular sarcoidosis were asymptomatic [4] , so ophthalmic screening may be necessary. 
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DOES THE PREVALENCE OF CENTRAL NERVOUS SYSTEM INVOLVEMENT INCREASE WHEN OCULAR SARCOIDOSIS IS FOUND IN OPHTHALMIC SCREENING?
The prevalence of central nervous system (CNS) involvement when ocular sarcoidosis was found in ophthalmic screening has been reported to vary between 237% [9] . Therefore, it is difficult to determine if ocular sarcoidosis is associated with CNS involve ment.
WHAT ARE THE DIAGNOSTIC CRITERIA FOR OCULAR SARCOIDOSIS?
In tive, but at least 4 of the above signs and 2 positive laboratory in vestigations were present, the condition was labeled as possible oc ular sarcoidosis [26] .
OPHTHALMOLOGIC TREATMENT OF OCULAR SARCOIDOSIS
Because sarcoidosis is a disease involving the entire body, a sys temic treatment needs to be considered prior to ophthalmic treat ment. However, as there are ophthalmic complications and local ized treatment is necessary for these, this discussion is limited to the treatment for complications of sarcoidosis in ophthalmology only.
Use of corticosteroid
Administration of a systemic steroid is possible, but topical ad ministration can be also considered, as shown below, for the treat ment of ophthalmic complications.
1) Topical corticosteroid
A topical corticosteroid is used to control anterior uveitis, and the systemic effects are minimal. Topical steroids administered as an eye drop do not reach the therapeutic dose as their concentra tion in the vitreous body is too low. Therefore, administration of a topical corticosteroid eye drop is usually used only in the treatment of anterior uveitis. Its wellknown side effects include an increase of ocular pressure and cataracts.
2) Regional corticosteroid injection and implant in cystoid macular edema, posterior uveitis, panuveitis, and inter mediate uveitis [27] . As this treatment method may increase ocu lar pressure, this must be monitored. 
Biologic agent
For the treatment of nonresponsive uveitis, using a biologic agent such as tumor necrosis factorα inhibitor can be considered. Etan 
CONCLUSION
Because sarcoidosis is a disease involving the entire body, the eyes, orbits, and optic nerve may be all involved. The rate of ocular involvement among patients with sarcoidosis is high, and because asymptomatic ocular involvement among these is also high, oph thalmic screening is necessary. Specifically, ophthalmic screening such as conjunctival biopsy can be helpful in the definitive diag nosis of sarcoidosis, and it is essential for establishing a system of collaborative treatments. For the management of ophthalmic com plications, there are not only systemic medications, but also local ized treatment for use in the eyes only, and these may be used sep arately from the systemic medications.
